CLINICAL_TRIALS
trial_result
· 2014-03-28
Clinical Trial Update: Study of Rifampicin in Multiple System Atrophy [Phase 3]
Summary
Phase 3 study of rifampicin in Multiple System Atrophy was terminated; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Phillip Low | Conditions: Multiple System Atrophy | Phase 3 | Status: TERMINATED | Results posted: 2014-03-28